Transaction · 0001662982-26-000006
ONCBeOne Medicines Ltd.
Wang Xiaodong
Wang Xiaodong, DIR, reported an open-market or private sale at BeOne Medicines Ltd. involving 10361.000000 shares for an estimated $3631262.15. Reported holdings after the transaction were 13499.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SDIR
- Trade date
- Oct 13, 2026
- Filing date
- Oct 15, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 23,860 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ONC price since this filing
Daily closing prices, with the filing date and available return windowsONC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.4%1w ago -3.0%1d ago -6.3%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001662982-26-000006 American Depositary Shares
- Transaction date
- Oct 13, 2026 Filed Oct 15, 2026, 09:08 PM · 2d delay
- Shares
- 10,361 sh $350.47 per share
- Estimated value
- -$3.63M Computed from shares × price
- Holdings after
- 13,499 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Holdings Reduction Large Sale Repeat Seller 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther Yes
Footnotes & amended
- F1
These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
- F2
These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a tr…
- F3
These securities are held by the spouse of the Reporting Person.
- F4
Each American Depositary Share represents 13 Ordinary Shares.
- F5
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.98 to $349.97, inclusive. The Reporting Person has provided to t…
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.98 to $350.97, inclusive. The Reporting Person has provided to t…
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.98 to $351.97, inclusive. The Reporting Person has provided to t…
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.99 to $352.95, inclusive. The Reporting Person has provided to t…
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $353.325, inclusive. The Reporting Person has provided to…
- F11
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F12
These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject…
Related transactions
Same SEC filing0 other transactions
Recent company activity
ONC0 recent txs